A new trading day began on Friday, with GE HealthCare Technologies Inc (NASDAQ: GEHC) stock price down -0.38% from the previous day of trading, before settling in for the closing price of $90.62. GEHC’s price has ranged from $62.35 to $94.50 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 4.14%. Meanwhile, its annual earnings per share averaged 8.11%. With a float of $424.97 million, this company’s outstanding shares have now reached $455.34 million.
Let’s determine the extent of company efficiency that accounts for 51000 employees.
GE HealthCare Technologies Inc (GEHC) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Medical Devices Industry. The insider ownership of GE HealthCare Technologies Inc is 6.94%, while institutional ownership is 76.05%. The most recent insider transaction that took place on Aug 14 ’24, was worth 1,581,846. In this transaction Ch. Supply Chain & Serv. Ofc. of this company sold 19,008 shares at a rate of $83.22, taking the stock ownership to the 38,541 shares. Before that another transaction happened on Aug 14 ’24, when Company’s Officer proposed sale 19,008 for $82.74, making the entire transaction worth $1,572,774.
GE HealthCare Technologies Inc (GEHC) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 8.11% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 10.80% during the next five years compared to -2.54% drop over the previous five years of trading.
GE HealthCare Technologies Inc (NASDAQ: GEHC) Trading Performance Indicators
Here are GE HealthCare Technologies Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 0.77. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.11. Likewise, its price to free cash flow for the trailing twelve months is 25.50.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 3.45, a number that is poised to hit 1.05 in the next quarter and is forecasted to reach 4.74 in one year’s time.
Technical Analysis of GE HealthCare Technologies Inc (GEHC)
Looking closely at GE HealthCare Technologies Inc (NASDAQ: GEHC), its last 5-days average volume was 4.79 million, which is a jump from its year-to-date volume of 3.02 million. As of the previous 9 days, the stock’s Stochastic %D was 89.81%. Additionally, its Average True Range was 1.94.
During the past 100 days, GE HealthCare Technologies Inc’s (GEHC) raw stochastic average was set at 94.89%, which indicates a significant increase from 89.36% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 22.28% in the past 14 days, which was lower than the 32.57% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $83.97, while its 200-day Moving Average is $81.82. However, in the short run, GE HealthCare Technologies Inc’s stock first resistance to watch stands at $91.07. Second resistance stands at $91.87. The third major resistance level sits at $92.61. If the price goes on to break the first support level at $89.54, it is likely to go to the next support level at $88.80. Now, if the price goes above the second support level, the third support stands at $88.01.
GE HealthCare Technologies Inc (NASDAQ: GEHC) Key Stats
With a market capitalization of 41.23 billion, the company has a total of 456,465K Shares Outstanding. Currently, annual sales are 19,552 M while annual income is 1,568 M. The company’s previous quarter sales were 4,839 M while its latest quarter income was 428,000 K.
